阿尔茨海默病中调节脑脊液Tau生物标志物的β-淀粉样蛋白依赖性和非依赖性遗传通路
在瑞典BioFINDER研究中,分析阿尔茨海默病多基因风险评分(排除APOE区域)与脑脊液生物标志物的关联,并在ADNI数据集验证。结果显示,多基因风险评分与脑脊液P-tau181和T-tau升高相关,部分由Aβ病理介导(37%),也存在Aβ非依赖通路,但与神经丝轻链无关联。
要点
- 多基因风险评分(约1742个变异)与脑脊液P-tau181(β=0.13,p=5.6e-05)和T-tau(β=0.12,p=4.3e-04)升高相关。
- Aβ病理介导了该多基因风险评分对tau水平效应的37%。
- 多基因风险评分与脑脊液Aβ生物标志物关联仅达名义显著性,校正多重比较后不显著;与神经丝轻链无关联。
主要发现
- SNP显著性阈值p<5e-03(约1742个变异)的多基因风险评分与较高的脑脊液P-tau181(β=0.13,p=5.6e-05)和T-tau(β=0.12,p=4.3e-04)相关。
- 校正Aβ状态后,多基因风险评分与tau指标的关联部分减弱但仍显著。
- Aβ病理介导了该多基因风险评分对tau水平效应的37%。
- 鉴定并表征了多基因风险评分的Aβ依赖性和Aβ非依赖性亚组。
- 多基因风险评分与脑脊液Aβ生物标志物存在名义显著性关联,但校正多重比较后不显著;与脑脊液神经丝轻链无关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Abnormal metabolism of β-amyloid (Aβ) and soluble phosphorylated tau (P-tau), as well as neurodegeneration, are key components of Alzheimer disease (AD), but it is unclear how these different processes are related to genetic risk factors for AD. METHODS: In the Swedish BioFINDER study, we tested associations between a priori defined polygenic risk scores (PRSs) for AD (excluding single-nucleotide polymorphism [SNP] within the APOE region in the main analysis) and biomarkers in CSF (total tau [T-tau] and P-tau181; Aβ1-38, Aβ1-40, Aβ1-42, and Aβ1-42/1-40; and neurofilament light [NfL]) in cognitively unimpaired (CU) individuals (n = 751), and in patients with mild cognitive impairment (MCI) (n = 212) and AD dementia (n = 150). Results were validated in the Alzheimer's Disease Neuroimaging Initiative data set with 777 individuals (AD = 119, MCI = 442, and CU = 216). RESULTS: PRSs with SNPs significant at p < 5e-03 (∼1,742 variants) were associated with higher CSF P-tau181 (β = 0.13, p = 5.6e-05) and T-tau (β = 0.12, p = 4.3e-04). The associations between PRS and tau measures were partly attenuated but remained significant after adjusting for Aβ status. Aβ pathology mediated 37% of the effect of this PRS on tau levels. Aβ-dependent and Aβ-independent subsets of the PRS were identified and characterized. There were also associations between PRSs and CSF Aβ biomarkers with nominal significance, but not when corrected for multiple comparisons. There were no associations between PRSs and CSF NfL. DISCUSSION: Genetic pathways implicated in causing AD are related to altered levels of soluble tau through both Aβ-dependent and Aβ-independent mechanisms, which may have relevance for anti-tau drug development.
引用
- Kumar A, Janelidze S, Stomrud E, et al. β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease. Neurology. 2022. PMID: 35641311. doi:10.1212/WNL.0000000000200605
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。